8-KEarnings & ResultsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Jan 27, 2011)

Filed January 27, 2011For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K report on January 27, 2011, to announce its financial results for the fourth quarter and full year of 2010. The report primarily directs investors to a press release issued on the same date, which contains the detailed financial performance information. This filing serves as formal notification of the release of these results to the market. Investors seeking to understand BMY's performance in late 2010 should refer to the press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) attached to this 8-K. These documents would typically cover key financial metrics such as revenue, earnings per share (EPS), and potentially provide commentary on product performance, strategic developments, and future outlook.

Key Highlights

  • 1BMY announced its Q4 and Full Year 2010 financial results on January 27, 2011.
  • 2The 8-K filing formally discloses the release of these financial results.
  • 3Key financial data is contained within the press release furnished as Exhibit 99.1.
  • 4Additional supplemental information is available on the company's website as Exhibit 99.2.
  • 5This report is a standard disclosure mechanism for material financial events.
  • 6Investors are directed to the attached exhibits for detailed performance analysis.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and provide access to Bristol-Myers Squibb's financial results for the fourth quarter and the full year of 2010, as reported on January 27, 2011.

The detailed financial results are primarily located in the press release issued by Bristol-Myers Squibb on January 27, 2011, which is furnished as Exhibit 99.1 to this 8-K. Supplemental information is also available as Exhibit 99.2.

The financial information covered by this filing pertains to the fourth quarter and the twelve months (full year) of 2010.

This specific 8-K filing itself does not provide an in-depth analysis. It serves as a notification and directs investors to the accompanying press release (Exhibit 99.1) and supplemental information (Exhibit 99.2), which would contain the company's commentary and analysis of the results.